May & Baker, a manufacturer, and distributor of pharmaceutical products in its recently released nine-month financial results for the period ended September 2022 has reported a 62 percent increase in profit to N1.43 billion from N882.4 million in the corresponding period of 2021, the highest rep
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Folake Balogun
Folake Balogun is a tech journalist covering Africa’s fast-growing digital economy with a strong focus on incisive analysis of startup trends, venture capital, and fintech innovation, while also exploring emerging technologies such as artificial intelligence and the future of connectivity by highlighting their economic and social impact.
